CIK 0001368514 · Large accelerated filer
ADMA BIOLOGICS, INC.
Sign in to watch- Ticker
- ADMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562590442
- Phone
- (201) 478-5552
- Business address
- C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
- Former names
- R&R ACQUISITION VI, INC
- PRE 14A Proxy Proxy Statement (Preliminary)
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award President and CEO acquired 221,447 shares (grant or award)
- 4 Grant or award EVP, CSO and CMO acquired 64,361 shares (grant or award)
- 4 Grant or award EVP, CFO acquired 63,936 shares (grant or award)
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Results of operations
Page 20 of 50 · 1,000 filings